219 related articles for article (PubMed ID: 18676679)
1. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.
Xiang N; Zhao R; Song G; Zhong W
Carcinogenesis; 2008 Nov; 29(11):2175-81. PubMed ID: 18676679
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Nandakumar V; Vaid M; Katiyar SK
Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
[TBL] [Abstract][Full Text] [Related]
3. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.
Pandey M; Shukla S; Gupta S
Int J Cancer; 2010 Jun; 126(11):2520-33. PubMed ID: 19856314
[TBL] [Abstract][Full Text] [Related]
4. A reciprocal role of prostate cancer on stromal DNA damage.
Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
[TBL] [Abstract][Full Text] [Related]
5. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
[TBL] [Abstract][Full Text] [Related]
6. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
7. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
8. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
Singal R; van Wert J; Bashambu M
Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
[TBL] [Abstract][Full Text] [Related]
9. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.
Zhou Q; Atadja P; Davidson NE
Cancer Biol Ther; 2007 Jan; 6(1):64-9. PubMed ID: 17172825
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
Milutinovic S; Brown SE; Zhuang Q; Szyf M
J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
[TBL] [Abstract][Full Text] [Related]
13. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.
Kondo Y; Shen L; Issa JP
Mol Cell Biol; 2003 Jan; 23(1):206-15. PubMed ID: 12482974
[TBL] [Abstract][Full Text] [Related]
14. Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer.
Okino ST; Pookot D; Majid S; Zhao H; Li LC; Place RF; Dahiya R
Mol Carcinog; 2007 Oct; 46(10):839-46. PubMed ID: 17415778
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S
Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide.
Hauptstock V; Kuriakose S; Schmidt D; Düster R; Müller SC; von Ruecker A; Ellinger J
Biochem Biophys Res Commun; 2011 Sep; 412(4):606-11. PubMed ID: 21855532
[TBL] [Abstract][Full Text] [Related]
18. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Meeran SM; Patel SN; Tollefsbol TO
PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]